Corcept Therapeutics
CORT
CORT
273 hedge funds and large institutions have $2.79B invested in Corcept Therapeutics in 2023 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 82 increasing their positions, 93 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
11% more funds holding
Funds holding: 245 → 273 (+28)
3.08% more ownership
Funds ownership: 80.4% → 83.49% (+3.1%)
12% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 93
Holders
273
Holding in Top 10
5
Calls
$49.6M
Puts
$40.6M
Top Buyers
| 1 | +$44.4M | |
| 2 | +$39.3M | |
| 3 | +$26.8M | |
| 4 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$15.2M |
| 5 |
QC
Quantedge Capital
Singapore
|
+$8.07M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$15.9M | |
| 3 | -$14.2M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$8.75M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$6.23M |